Irisin and Myostatin Levels in Patients with Graves' Disease

Bartalena, 2013, Diagnosis and management of Graves disease: a global overview, Nat Rev Endocrinol, 9, 724, 10.1038/nrendo.2013.193 Franklyn, 2012, Thyrotoxicosis, Lancet, 379, 1155, 10.1016/S0140-6736(11)60782-4 Salvatore, 2014, Thyroid hormones and skeletal muscle–new insights and potential implications, Nat Rev Endocrinol, 10, 206, 10.1038/nrendo.2013.238 Kung, 2007, Neuromuscular complications of thyrotoxicosis, Clin Endocrinol, 67, 645, 10.1111/j.1365-2265.2007.02909.x Norrelund, 1999, Muscle mass and function in thyrotoxic patients before and during medical treatment, Clin Endocrinol, 51, 693, 10.1046/j.1365-2265.1999.00861.x Simonides, 2008, Thyroid hormone as a determinant of metabolic and contractile phenotype of skeletal muscle, Thyroid, 18, 205, 10.1089/thy.2007.0256 Lee, 2014, Thyroid hormone signaling in muscle development, repair and metabolism, J Endocrinol, 2, 1046 Tohma, 2015, Circulating levels of orexin-A, nesfatin-1, Agouti-related peptide, and neuropeptide Y in patients with hyperthyroidism, Thyroid, 25, 776, 10.1089/thy.2014.0515 Riis, 2005, Hyperthyroidism and cation pumps in human skeletal muscle, Am J Physiol Endocrinol Metab, 288, 1265, 10.1152/ajpendo.00533.2004 Iizuka, 2014, Skeletal muscle is an endocrine organ, J Pharmacol Sci, 125, 125, 10.1254/jphs.14R02CP Pedersen, 2012, Muscles, exercise and obesity: skeletal muscle as a secretory organ, Nat Rev Endocrinol, 8, 457, 10.1038/nrendo.2012.49 Hofmann, 2014, Irisin as a muscle-derived hormone stimulating thermogenesis–a critical update, Peptides, 54, 89, 10.1016/j.peptides.2014.01.016 Sharma, 2015, Myostatin: Expanding horizons, IUBMB Life, 67, 589, 10.1002/iub.1392 Argiles, 2012, Myostatin: more than just a regulator of muscle mass, Drug Discov Today, 17, 702, 10.1016/j.drudis.2012.02.001 McPherron, 1997, Regulation of skeletal muscle mass in mice by a new TGF-β superfamily member, Nature, 387, 83, 10.1038/387083a0 McPherron, 2010, Metabolic functions of myostatin and Gdf11, Immunol Endocr Metab Agents Med Chem, 10, 217, 10.2174/187152210793663810 Samy, 2015, Circulating irisin concentrations in rat models of thyroid dysfunction–-effect of exercise, Metabolism, 64, 804, 10.1016/j.metabol.2015.01.001 Ruchala, 2014, Serum irisin levels and thyroid function–newly discovered association, Peptides, 60, 51, 10.1016/j.peptides.2014.07.021 Carneiro, 2008, Hypothyroidism is associated with increased myostatin expression in rats, J Endocrinol Invest, 31, 773, 10.1007/BF03349256 Postler, 2009, Influence of hyperthyroid conditions on gene expression in extraocular muscles of rats, Physiol Genomics, 37, 231, 10.1152/physiolgenomics.00023.2009 Matthews, 1985, Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man, Diabetologia, 28, 412, 10.1007/BF00280883 Stengel, 2013, Circulating levels of irisin in patients with anorexia nervosa and different stages of obesity–correlation with body mass index, Peptides, 39, 125, 10.1016/j.peptides.2012.11.014 Gouni-Berthold, 2013, Effects of lipid-lowering drugs on irisin in human subjects in vivo and in human skeletal muscle cells ex vivo, PLoS One, 8, e72858, 10.1371/journal.pone.0072858 Panagiotou, 2016, Changes of thyroid hormone levels within the normal and/or subclinical hyper- or hypothyroid range do not affect circulating irisin levels in humans, Thyroid, 26, 1039, 10.1089/thy.2016.0098 Tozzoli, 2012, TSH receptor autoantibody immunoassay in patients with Graves' disease: improvement of diagnostic accuracy over different generations of methods. Systematic review and meta-analysis, Autoimmun Rev, 12, 107, 10.1016/j.autrev.2012.07.003 Irrcher, 2003, PPARgamma coactivator-1alpha expression during thyroid hormone- and contractile activity-induced mitochondrial adaptations, Am J Physiol Cell Physiol, 284, 1669, 10.1152/ajpcell.00409.2002 Ranka, 2003, Serum creatine phosphokinase in thyroid disorders, Indian J Clin Biochem, 18, 107, 10.1007/BF02867676 Mitrou, 2010, Insulin action in hyperthyroidism: a focus on muscle and adipose tissue, Endocr Rev, 31, 663, 10.1210/er.2009-0046 Elliott, 2012, The central role of myostatin in skeletal muscle and whole body homeostasis, Acta Physiol (Oxf), 205, 324, 10.1111/j.1748-1716.2012.02423.x